HairDX Enters Into Exclusive Distribution Agreement With Aderans
Pharmacogenomics research and development innovator
PharmaGenoma, Inc. and its subsidiary HairDX, LLC (www.hairdx.com), pioneers genetic tests for
predicting the risk of male and female hair loss, today announced an exclusive agreement with
Aderans Company Limited of Tokyo to introduce the breakthrough tests in Japan starting on
March 1, 2009. The HairDX test collection kit is listed with Japan's Pharmaceuticals and Medical
Devices Agency (PMDA) as a Class I medical device.
The agreement makes Aderans the sole Japanese distributor of HairDX’s revolutionary genetic
tests, and further expands Aderans’ leadership in the hair care and medical fields. Aderans and its
group of companies span over 17 countries worldwide, and in 2001 Aderans purchased Bosley,
Inc., one of the world’s largest brands in hair transplant, to further solidify its global position as a
leading company in the hair care industry.
“PharmaGenoma is a leader in molecular dermatology and is excited to bring the latest in genetic
science to Japan. We believe our partnership with Aderans will benefit millions of Japanese men
and women concerned about hair loss,” says Andy Goren, President & CEO of PharmaGenoma,
Inc.
HairDX’s simple genetic test provides an accurate and understandable genetic analysis of a man’s
or woman’s likelihood of developing Androgenetic Alopecia, the most common type of hair loss.
”Aderans partnership with HairDX will allow people in Japan to learn their risk for hair loss early, so
they can choose the best treatment to preserve their hair,” says Katsuji Tokumaru, President of
Aderans Co. Ltd.
About HairDX, LLC
HairDX, LLC (www.hairdx.com) is a subsidiary of PharmaGenoma, Inc. Based in Irvine, CA, USA.
HairDX is a molecular dermatology research and development company. HairDX markets the first
genetic test for male and female hair loss. The company is dedicated to the research and
development of new prescription based therapies tailored to an individual's genetic make up.
HairDX uses only CLIA certified laboratories (Clinical Laboratory Improvement Amendments) to
perform the genetic analysis. The HairDX test collection kit is listed with Japan's Pharmaceuticals
and Medical Devices Agency (PMDA) and the United States Food and Drug Administration (FDA)
as a Class I medical device.
Among HairDX leaders is William V. Murray former Division President of the Molecular Biology
Division of Applied BioSystems, Inc., who formerly served in various executive leadership
positions within Medtronic, Inc., Andy Goren former CEO of MobileWise, Inc. and GeePS, Inc.,
Professor Doron Lancet, PhD, Head of the Crown Human Genome Center at the Department of
Molecular Genetics, Weizmann Institute of Science, Dr. Elon Pras, Director of the Institute of
Human Genetics, Sheba Medical Center in Tel-Hashomer, Israel, Sharon Keene, MD and
President and Medical Director of Physician's Hair Institute, in Tucson, Arizona and nationally
recognized for her pioneering work in the hair transplant field, and Elliott J. Stein, an intellectual
property attorney and co-founder of GeePS, Inc.
About Aderans Co. Ltd.
Headquartered in Tokyo, Japan, The Aderans Group offers a comprehensive lineup of products
and services to successfully address whatever concerns people may have about their hair. The
Group operates a variety of hair-related businesses targeting men and women in Japan and
overseas. In addition to manufacturing and selling custom-made and ready-made wigs and
hairpieces, the Group assists with healthy hair growth, hair-transplant and other hair-related
services. It also undertakes research and development into hair-regeneration technology. The
Group’s global presence includes bases in 15 nations, mainly spanning North America, Europe
and Asia. To drive further growth, the Group is marshalling all its resources to establish itself as a
total hair solution company
Pharmacogenomics research and development innovator
PharmaGenoma, Inc. and its subsidiary HairDX, LLC (www.hairdx.com), pioneers genetic tests for
predicting the risk of male and female hair loss, today announced an exclusive agreement with
Aderans Company Limited of Tokyo to introduce the breakthrough tests in Japan starting on
March 1, 2009. The HairDX test collection kit is listed with Japan's Pharmaceuticals and Medical
Devices Agency (PMDA) as a Class I medical device.
The agreement makes Aderans the sole Japanese distributor of HairDX’s revolutionary genetic
tests, and further expands Aderans’ leadership in the hair care and medical fields. Aderans and its
group of companies span over 17 countries worldwide, and in 2001 Aderans purchased Bosley,
Inc., one of the world’s largest brands in hair transplant, to further solidify its global position as a
leading company in the hair care industry.
“PharmaGenoma is a leader in molecular dermatology and is excited to bring the latest in genetic
science to Japan. We believe our partnership with Aderans will benefit millions of Japanese men
and women concerned about hair loss,” says Andy Goren, President & CEO of PharmaGenoma,
Inc.
HairDX’s simple genetic test provides an accurate and understandable genetic analysis of a man’s
or woman’s likelihood of developing Androgenetic Alopecia, the most common type of hair loss.
”Aderans partnership with HairDX will allow people in Japan to learn their risk for hair loss early, so
they can choose the best treatment to preserve their hair,” says Katsuji Tokumaru, President of
Aderans Co. Ltd.
About HairDX, LLC
HairDX, LLC (www.hairdx.com) is a subsidiary of PharmaGenoma, Inc. Based in Irvine, CA, USA.
HairDX is a molecular dermatology research and development company. HairDX markets the first
genetic test for male and female hair loss. The company is dedicated to the research and
development of new prescription based therapies tailored to an individual's genetic make up.
HairDX uses only CLIA certified laboratories (Clinical Laboratory Improvement Amendments) to
perform the genetic analysis. The HairDX test collection kit is listed with Japan's Pharmaceuticals
and Medical Devices Agency (PMDA) and the United States Food and Drug Administration (FDA)
as a Class I medical device.
Among HairDX leaders is William V. Murray former Division President of the Molecular Biology
Division of Applied BioSystems, Inc., who formerly served in various executive leadership
positions within Medtronic, Inc., Andy Goren former CEO of MobileWise, Inc. and GeePS, Inc.,
Professor Doron Lancet, PhD, Head of the Crown Human Genome Center at the Department of
Molecular Genetics, Weizmann Institute of Science, Dr. Elon Pras, Director of the Institute of
Human Genetics, Sheba Medical Center in Tel-Hashomer, Israel, Sharon Keene, MD and
President and Medical Director of Physician's Hair Institute, in Tucson, Arizona and nationally
recognized for her pioneering work in the hair transplant field, and Elliott J. Stein, an intellectual
property attorney and co-founder of GeePS, Inc.
About Aderans Co. Ltd.
Headquartered in Tokyo, Japan, The Aderans Group offers a comprehensive lineup of products
and services to successfully address whatever concerns people may have about their hair. The
Group operates a variety of hair-related businesses targeting men and women in Japan and
overseas. In addition to manufacturing and selling custom-made and ready-made wigs and
hairpieces, the Group assists with healthy hair growth, hair-transplant and other hair-related
services. It also undertakes research and development into hair-regeneration technology. The
Group’s global presence includes bases in 15 nations, mainly spanning North America, Europe
and Asia. To drive further growth, the Group is marshalling all its resources to establish itself as a
total hair solution company
No comments:
Post a Comment